ERBB2 and breast cancer: In this study, we carried out a detailed quantitative high‐throughput LC‐MS/MS profiling of the protein complement of interstitial fluid samples, recovered from breast tumors of three main subtypes: luminal, Her2, and TNBC as well as from nonmalignant counterparts obtained from women with untreated BC, who underwent mastectomy at the Copenhagen University Hospital.